Related Experiment Video
Updated: Jun 20, 2026
10:49
Intraspinal Cell Transplantation for Targeting Cervical Ventral Horn in Amyotrophic Lateral Sclerosis and Traumatic Spinal Cord Injury
Published on: September 18, 2011
Amyotrophic lateral sclerosis and occupational exposure to electromagnetic fields
Z Davanipour1, E Sobel, J D Bowman
1Department of Neurology, University of Southern California School of Medicine, Los Angeles 90033, USA.
Bioelectromagnetics
|January 1, 1997
Summary
This study suggests a potential link between occupational electromagnetic field (EMF) exposure and amyotrophic lateral sclerosis (ALS). Higher EMF exposure levels were associated with increased odds of developing ALS in this case-control study.
Area of Science:
- Neuroscience
- Environmental Health
- Epidemiology
Background:
- Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease with largely unknown etiology.
- Occupational exposures are increasingly recognized as potential contributing factors to neurodegenerative diseases.
Purpose of the Study:
- To investigate the association between occupational exposure to electromagnetic fields (EMFs) and amyotrophic lateral sclerosis (ALS) in a case-control study.
- To generate hypotheses for future research on environmental risk factors for ALS.
Main Methods:
- A case-control study was conducted with 28 ALS patients and 32 controls (relatives).
- Lifetime occupational histories were collected, and EMF exposure was assessed blindly based on job classifications and duration.
- Two exposure indices, total occupational exposure (E1) and average occupational exposure (E2), were calculated.
Main Results:
- For subjects with at least 20 years of work experience, the odds ratio (OR) for high EMF exposure (75th percentile) was 7.5 for E1 (P < 0.02) and 5.5 for E2 (P < 0.02).
- For all subjects, ORs for high EMF exposure were 2.5 for E1 (P < 0.1) and 2.3 for E2 (P = 0.12).
Conclusions:
- This hypothesis-generating study indicates a potential association between occupational EMF exposure and ALS.
- Further research with larger sample sizes, incident cases, and refined exposure assessment is warranted to confirm these findings.
Related Concept Videos
01:26Cross-bridge Cycle
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...